• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

FDA Clearance

FDA Approves Drug-Free AI-Powered Wearable for Nasal Congestion for Kids

by Jasmine Pennic 06/04/2025 Leave a Comment

FDA Approves Pediatric Drug-Free AI-Powered Wearable for Nasal Congestion

What You Should Know:  - SoundHealth, a medical technology company leveraging artificial intelligence and medical science, recently announced it has received U.S. Food and Drug Administration (FDA) approval for pediatric use of its SONU Band.  - The AI-enabled wearable device is now cleared as the first FDA-approved, drug-free solution for treating moderate to severe nasal congestion due to allergic and non-allergic rhinitis in children aged 12 and up, offering a safe alternative
Read More

Arineta’s SpotLight Duo CT Scanner Receives FDA Clearance for Low-Dose Lung Cancer Screening

by Jasmine Pennic 05/19/2025 Leave a Comment

Arineta's SpotLight Duo CT Scanner Receives FDA Clearance for Low-Dose Lung Cancer Screening

What You Should Know:  - Arineta, a leader in advancing cardiovascular imaging solutions, announced that its SpotLight™ Duo cardiac CT scanner has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for low-dose lung cancer screening (LDCT).  - The regulatory milestone allows healthcare providers to utilize a single, ultra-fast CT platform for both comprehensive cardiac imaging and vital lung cancer screening, offering more complete and efficient care for
Read More

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

by Fred Pennic 05/08/2025 Leave a Comment

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

What You Should Know:  - Osteoboost Health announced the nationwide availability of Osteoboost, a groundbreaking prescription medical device. Osteoboost aims to provide hope for millions diagnosed with low bone density, helping to reduce the risk of fractures that can severely impact mobility and independence. - As the first and only FDA-cleared device of its kind for low bone density, Osteoboost introduces a novel, protective, and preventative approach to bone health, offering a new
Read More

World’s First AI Lung Sound Suite: TytoCare Gets FDA Clearance for Rhonchi

by Fred Pennic 04/15/2025 Leave a Comment

World's First AI Lung Sound Suite: TytoCare Gets FDA Clearance for Rhonchi

What You Should Know:  - TytoCare, a pioneering virtual care company dedicated to delivering accessible, high-quality primary care from the comfort of home announced the company has become the first in the world to receive FDA clearance for its AI-based detection of all three major abnormal lung sounds.  - The milestone was reached with the FDA clearance of Tyto Insights™ for Rhonchi Detection, completing TytoCare’s comprehensive AI-powered lung sound suite. With this latest
Read More

Click Therapeutics Obtains FDA Authorization for First Prescription Digital Therapeutic for Migraine Prevention

by Fred Pennic 04/15/2025 Leave a Comment

Click Therapeutics Obtains FDA Authorization for First Prescription Digital Therapeutic for Migraine Prevention

What You Should Know:  - Click Therapeutics, Inc. (“Click”), a leader in the rapidly evolving field of prescription medical treatments, encompassing both prescription digital therapeutics (PDTs) and software-enhanced drug™ therapies has received FDA marketing authorization for CT-132, the first prescription digital therapeutic specifically indicated for the preventive treatment of episodic migraine in adults aged 18 and older. - The FDA granted a De Novo Classification Request for
Read More

Tandem Diabetes Care Receives FDA Clearance for Control-IQ+ Technology for Type 2 Diabetes

by Jasmine Pennic 02/25/2025 Leave a Comment

Tandem Diabetes Care Receives FDA Clearance for Control-IQ+ Technology for Type 2 Diabetes

What You Should Know:  - Tandem Diabetes Care, a insulin delivery and diabetes technology company, announced that its Control-IQ+ technology has received clearance from the U.S. Food and Drug Administration (FDA) for use by adults with type 2 diabetes.  - The expanded indication builds on the success of Control-IQ+ in type 1 diabetes and offers a new automated insulin delivery (AID) option for individuals with type 2 diabetes. Improve Glycemic Control for Adults with Type 2
Read More

Ezra Receives FDA Clearance for Enhanced AI-Powered MRI Technology

by Fred Pennic 02/20/2025 Leave a Comment

Ezra Receives FDA Clearance for Enhanced AI-Powered MRI Technology

What You Should Know:  - Ezra, a innovator in AI-driven cancer screening, today announced that its advanced Ezra Flash AI model has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).  - The FDA clearance expands the capabilities of its AI-powered platform to provide faster, more affordable, and higher-quality full-body MRI scans. Ezra Flash AI for MRI Image Quality Ezra Flash, a Class II medical device, now enhances image quality for neuro, abdomen,
Read More

Movano Health Receives FDA Clearance for Evie Ring Pulse Oximeter

by Jasmine Pennic 12/03/2024 Leave a Comment

Movano Health Receives FDA Clearance for Evie Ring Pulse Oximeter

What You Should Know:  - Movano Health, a health technology innovator, has achieved a significant milestone with the FDA 510(k) clearance of the pulse oximeter integrated into its Evie Ring.  - The FDA clearance paves the way for Movano to pursue new opportunities in health monitoring solutions, including clinical trials, post-clinical management, and remote patient monitoring. Addressing the Limitations of Traditional Pulse Oximeters Traditional pulse oximeters can be
Read More

RSNA: Nonin Medical Launches First FDA-Cleared OTC Fingertip Pulse Oximeter for Accurate Readings Across Skin Tones

by Fred Pennic 12/02/2024 Leave a Comment

What You Should Know:  - Nonin Medical, a global leader in noninvasive medical monitoring lauches TruO2 OTC, the first over-the-counter (OTC) fingertip pulse oximeter to receive FDA clearance. This innovative device is designed to provide accurate blood oxygen saturation readings for adults across all skin tones, empowering individuals to make informed healthcare decisions. - Nonin Medical's founder, Phil Isaacson, was the original inventor of the fingertip pulse oximeter.  The
Read More

GE HealthCare Receives FDA Clearance for SIGNA™ MAGNUS Head-Only MRI Scanner

by Syed Hamza Sohail 11/14/2024 Leave a Comment

GE HealthCare Receives FDA Clearance for SIGNA™ MAGNUS Head-Only MRI Scanner

What You Should Know: - GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS, a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner.  - This system offers new capabilities for both clinical imaging and neuroscience with the potential to aid in the detection of neurological, oncological, and psychiatric conditions. SIGNA MAGNUS: Advancing Neuroimaging with Cutting-Edge MRI Technology The FDA clearance of the SIGNA MAGNUS
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 10
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |